Categories: News

Availity Selects Experienced Healthcare Leader Bobbi Coluni as Chief Product Officer

JACKSONVILLE, Fla., Jan. 11, 2022 /PRNewswire/ — Availity, the nation’s largest real-time health information network, announced today that Bobbi Coluni has joined the company as chief product officer (CPO). In her role, Coluni is responsible for leading Availity’s product design and management, developing innovative solutions, and launching products for the healthcare market.

To download a photo of Bobbi Coluni, please click here.

“I’m very excited to welcome Bobbi to the Availity leadership team,” said Jim McNary, chief operating officer, Availity. “Her experience and expertise will be extremely valuable overseeing product management and working with stakeholders across the healthcare industry on dynamic solutions. As we explore new business opportunities in 2022, Availity will benefit from having Bobbi’s insights as well as her commitment to delivering strategic, results-oriented leadership.”  

In her most recent role, Coluni served as Leader of Payer Product Management at IBM Watson Health, where she was responsible for product innovation and evaluating new market opportunities. In this position, she managed the portfolio of solutions for health plans and employers that use data, analytics, and AI to boost quality, reduce costs, improve user experience, and reduce friction in healthcare.

“I’m eager to join Availity and influence the design, development, and launch of new products that aim to benefit the healthcare sector,” said Coluni. “Availity is in a unique position to support intelligent digital transformation in the market. I look forward to bringing my perspective and experience to drive innovation, problem-solving, and value for our customers.”

Prior to IBM, Coluni worked at Johnson & Johnson as Strategic Head of Product Management, where she led the digital health coaching product management team and helped organizations renew the health, energy, and performance of their employees and members. In her career, Coluni has worked with constituents across the healthcare ecosystem and also held leadership positions at Altarum Institute, Truven Health Analytics (Thomson Reuters), and Cerner Corporation.

About Availity 
Availity is the place where healthcare finds the answers needed to shift focus back to patient care. We work to solve communication challenges in healthcare by creating a richer, more transparent exchange of information among health plans, providers, and technology partners. As one of the nation’s largest health information networks, Availity facilitates billions of clinical, administrative, and financial transactions annually. Our suite of dynamic products, built on a powerful, intelligent platform, enables real-time collaboration for success in a competitive, value-based care environment. 

For more information, including an online demonstration, please visit www.availity.com or call 1.800.AVAILITY (282.4548).

Media Contacts:  
Maddie Noteboom
Amendola Communications for Availity
512.422.3425
maddie@acmarketingpr.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/availity-selects-experienced-healthcare-leader-bobbi-coluni-as-chief-product-officer-301458061.html

SOURCE Availity

Staff

Recent Posts

Angle PLC Announces Parsortix at European Breast Cancer Conference

PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT A LEADING EUROPEAN BREAST CANCER CONFERENCEANGLE presenting two…

1 hour ago

MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 22, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today…

4 hours ago

Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE

GENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY )…

4 hours ago

Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 22, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext…

4 hours ago

Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024

LAKE FOREST, CA / ACCESSWIRE / March 21, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally…

13 hours ago

Free Dementia Training in Alabama

Bring Dementia Education at No Cost to Your Skilled Nursing HomeTUSCALOOSA, AL / ACCESSWIRE /…

13 hours ago